Isabel Cunningham, MD

Isabel Cunningham is an adjunct associate research scientist in the Division of Hematology Oncology at Columbia University. She is currently elucidating mechanisms of resistance in leukemia after many years of patient care, clinical research, and teaching. She received her MD from Yale and trained in Hem-Onc at Memorial Sloan Kettering.

Most Recent Articles by Isabel Cunningham, MD

A Glimpse of ASH

A Glimpse of ASH

By

Dr Isabel Cunningham discusses some of the important studies presented at the 2016 ASH meeting.

Age and Acute Myeloid Leukemia: A Review of Current Literature

Age and Acute Myeloid Leukemia: A Review of Current Literature

By

Dr Isabel Cunningham reviews and highlights important, recently published articles with recommendations for treating elderly patients with acute myeloid leukemia (AML).

Isabel Cunningham Holds CML Question-and-Answer Session With Jane Apperley, MD

Isabel Cunningham Holds CML Question-and-Answer Session With Jane Apperley, MD

By

Isabel Cunningham, MD, advisory board member for CTA, asks Dr Apperley about how to treat patients with CML that cause specialists particular concern.

We Can Treat Hodgkin's Lymphoma Like Melanoma?

We Can Treat Hodgkin's Lymphoma Like Melanoma?

By

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Reflecting on Treatment Strategies for Acute Leukemia

Reflecting on Treatment Strategies for Acute Leukemia

By

Leukemia is sometimes a solid, metastatic, and invasive neoplasm, but this is forgotten when leukemia is viewed as only a "liquid" cancer.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters